Mariya N. Dmitrieva

Mariya N. Dmitrieva

Auto-generated profile, based on publicly available information

Mariya N. Dmitrieva

Ryazan State Medical University named after academician I.P. Pavlov

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2022 in Nauka Molodykh (Eruditio Juvenium)
Verified
Journal Article
Closed access
RURyazan State Medical University
Ryazan State Medical University
MRM. N. Ryabova
M. N. Ryabova
ASA. V. Seleznev
A. V. Seleznev
IFI. A. Fokin
I. A. Fokin
DSD. R. Shodiyev
D. R. Shodiyev
MDM. N. Dmitriyeva
M. N. Dmitriyeva
INTRODUCTION: Hyaluronic acid (HA) is a natural glycosaminoglycan which is an integral component of both the matrix of articular cartilage and synovial fluid with its unique rheological properties that are lost in gonarthrosis, which leads to a decrease of viscoelastic characteristics of the synovia and destruction of the cartilage. AIM: To evaluate the effectiveness and safety of the use of Hyapro sterile biopolymer synovial fluid prosthesis in a disposable syringe for intra-articular injection at a concentration of 1.5% — 2 ml in treatment of gonarthrosis. MATERIALS AND METHODS: From September 2020 to April 2022 at settings of the orthopedic department of Ryazan Regional Clinical Hospital, an open prospective non-comparative study of the effectiveness and safety of Hyapro sterile biopolymer synovial fluid prosthesis at a concentration of 1.5% — 2 ml in 30 patients with 2 to 3 stage gonarthrosis according to Kellgren–Lawrence scale was carried out. Prior to the treatment, and also 3 and 6 months after, the severity of clinical symptoms on VAS, WOMAC, Leken scales, the quality of life according to SF-36 questionnaire were registered; the biochemical markers namely cartilaginous oligomatrix peptide (COMP), metal matrix proteinase 3 (MMR 3) were determined with the use of StatFax enzyme-linked plate analyzer (Awareness Technology, USA). RESULTS: In general, the studied drug was well tolerated by patients: there were no typical for intra-articular injections cases of clinically important adverse reactions like prolonged pain at the injection site, expansion-like sensation, an elevation of local temperature, and changes in the color of skin or changes of the shape of the knee joint. Just transient local tenderness in 6.7% of injection cases was noted. We revealed a statistically significant decrease in serum MMR-3 levels by 6 months of follow-up, which reflects a reduction of the inflammatory component in osteoarthritis of the joint studied. Besides, a gradual increase in COMP levels by the 6th month of the study was found, which may be an evidence of activation of the protein after the course of treatment to replenish the cartilage matrix. The results on VAS, WOMAC scales, and Leken algofunctional index demonstrated similar positive dynamics: a statistically reliable decrease in such parameters as pain, stiffness, and impaired functioning by the 3rd month of follow-up compared with the initial level; this trend was remaining in 6 months. After 3 months of treatment, there was a reliable improvement of the quality of life on the subscale of the physical component of health compared with the initial level, which persisted until the end of the study. On the subscale of the psychological component of health, no changes were found during the period. CONCLUSION: The course use of Hyapro biopolymer synovial fluid prosthesis on the basis of hyaluronic acid thermally stabilized with mannitol, in symptomatic gonarthrosis of intermediate stages, permits safely and effectively reduce pain and the inflammatory response, improve the function of the affected joint through restoration of viscoelastic and protective properties of synovial fluid for up to at least 6 months, improving the quality of life of patients.

6 June 2023 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
DSD. R. Shodiev
D. R. Shodiev
VZValentina I. Zvyagina
Valentina I. Zvyagina
MRM. N. Ryabova
M. N. Ryabova
MDM. N. Dmitrieva
M. N. Dmitrieva
BACKGROUND: Currently, OA is considered a polyetiological disease, where several phenotypes are distinguished based on the leading role of a specific risk factor. It is assumed that each clinical phenotype corresponds to its own fundamental changes in various organs and systems. Modern experimental evidence of chondro-osteogenic activity allows us to consider melatonin as a potential drug for various types of osteoarticular pathology.AIM: To study clinical and biochemical changes and effects of melatonin in the metabolic phenotype of OA and insomnia.MATERIALS AND METHODS: The study involved patients with a metabolic phenotype of OA and healthy volunteers. The subjects were collected complaints and anamnesis, as well as general clinical and orthopedic examination. In the blood serum, markers of bone and cartilage metabolism were determined. Patients were asked to answer the questions of clinical scales to assess the quality of sleep, the functional state of the joints and quality of life.RESULTS: The study involved 36 patients. Participants were divided into 3 groups: group health patients — patients without articular pathology, sleep quality disorders and normal body mass index; control group- patients with metabolic phenotype of OA, insomnia and basic treatment for 30 days; experimental group — patients with a metabolic phenotype of OA and insomnia, whose basic treatment included melatonin (Melaxen®) at a dosage of 3 mg for 30 days. Statistically significant differences were observed between the initial levels of acid phosphatase (AP), bone isoenzyme alkaline phosphatase (ALP) and calcium (Ca) in the control and experimental groups. According to the results of screening for the detection of insomnia among patients with the metabolic phenotype of, there were statistically significant insomnological disorders compared to the group health patients, as well as significant differences in terms of pain, symptoms, activity and quality of life in general according to the KOOS and SF-36 scales. Correlation analysis showed moderate correlations with biochemical parameters in patients with OA metabolic phenotype groups. After the treatment there was a certain increase in the level of Ca and a decrease in the activity of ALP and АP in patients of experimental group in comparison with patients of control groups. There was a positive trend in the range of criteria of the KOOS and SF-36 scale in experimental groups, pronounced decrease in pain syndrome (P), symptoms (S) and an increase in the levels of daily activity (A) and the total indicator (Sum) in comparison with patients of control groups. Also as improved sleep quality on all scales in comparison with the control group. In control group, problems with the quality and quantity of sleep remained at the same level.CONCLUSION: In patients with the most pronounced indicators of clinical manifestations of OA, more active processes of bone remodeling. The higher the level of bone resorption markers, the greater the severity of the clinical course in patients with osteoarthritis, and the worse the quality of sleep in general. The addition of melatonin to the treatment regimen was associated with a decrease in serum activity of the bone isoenzyme of alkaline phosphatase, acid phosphatase, an increase in calcium levels, as well as with an improvement in sleep and clinical symptoms ОА.

2 April 2019 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Open access
PDF file
VAVladimir N. Abrosimov
Vladimir N. Abrosimov
AKAleksey V. Kosyakov
Aleksey V. Kosyakov
MDMaria N. Dmitrieva
Maria N. Dmitrieva
Aim. To study the relationship between parameters of cardiointervalometry and ergoreflex, and 6-minute walk test data in patients with chronic obstructive pulmonary disease (COPD). Materials and Methods. The study included 103 men, of them 63 patients with COPD, 40 patients of the control group. Functional assessment of external respiration and a 6-minute walk test were performed using Spiropalm 6MWT equipment (Cosmed, Italy). The autonomic status and the influence of the ergoreflex on it were assessed by the method of cardiointervalometry before, during and after the test with external peripheral vascular occlusion using Varicard hardware and software complex (LLC Ramena, Ryazan, Russia). Results. When performing a 6-minute walk test, significant differences were obtained between the groups of patients with COPD and of the control group in the majority of the studied parameters (p0.01). In 18 of 63 patients with COPD, the level of SpO2 in 6-minute walk test decreased by 4% (p0.01). The obtained result is of considerable importance for assessment of exercise tolerance in patients with COPD. In tests with external peripheral vascular occlusion in patients with COPD and of the control group, the index of activity of regulatory systems (IARS) increased in both groups. However, after completion of the test, the index in patients with COPD decreased below the initial values (p0.05), and in patients of the control group the changes were even more pronounced (p0.01). Patients with COPD were divided into groups depending on the distance covered in 6-minute walk test. Analysis of the data revealed a moderate positive correlation between the covered distance and the forced expiratory volume in the 1st second (FEV1, R=0.45, p0.01).The maximum level of the total effect of the autonomic regulation of blood circulation was recorded in patients who covered the minimum distance (227.7748.13 m) in 6-minute walk test. Besides, a moderate negative correlation between IARS and the results of 6-minute test was recorded (R=-0.34, p0.01). Conclusions. 1. For assessment of the functional status of patients in 6-minute walk test it is important to take measurement of saturation throughout the whole test. 2. The change in IARS values in the test with external peripheral vascular occlusion can be regarded as a reduction of the influence of reflex from the lower limb ergoreceptors on the functional condition of patients. 3. Patients with COPD showed a marked autonomic imbalance. IARS showed a moderate negative correlation with the distance covered in 6-minute walk test. 4. Maximum value of IARS was obtained in patients with the minimal distance covered in 6-minute walk test.

26 June 2022 in Journal of Experimental Biology and Agricultural Sciences
Verified
Journal Article
Open access
PDF file
ASAnna M. Shitikova
Anna M. Shitikova
MAMikhail M. Atroshchenko
Mikhail M. Atroshchenko
LKLidia V. Krokhotina
Lidia V. Krokhotina
MEMaria Engalycheva
Maria Engalycheva
MDMariya N. Dmitrieva
Mariya N. Dmitrieva
The effect of steroid hormones on the quality of fresh and cryopreserve sperm has not been fully understood. This study aimed to evaluate the effect of testosterone, dihydrotestosterone, estradiol, and cortisol on the quality of fresh and cryopreserved stallion sperm. The study was conducted on 40 Equus caballus stallions, including Arab (n=20), Oryol trotting (n=4), Standardbred (n=4), and Soviet Heavy Draft (n=12) breeds. The average age of the experimental animals was 9.9 ± 0.7 years. We determined standard quality indicators in fresh and cryopreserved sperm and the concentration of steroid hormones in the blood plasma of stallions. Results of the study suggested a negative correlation between the level of testosterone with total (r=-0.41; p<0.01) and progressive (r=-0.44; p<0.01) sperm motility in cryopreserved sperm as well as in fresh sperm (r=-0.38; p<0.05 and r=-0.39; p<0.05 correspondingly). While the level of estradiol showed a positive correlation with survival rate in cryopreserved (r=0.35; p<0.05) and in fresh (r=0.33; p<0.05) sperm. Further, the level of cortisol in the blood plasma of stallions did not show any statistically significant correlations with the qualitative characteristics of sperm. A positive relationship was found between the concentration of dihydrotestosterone with the volume of ejaculate (r=0.37; p<0.05) and the total number of sperm in the ejaculate (r=0.43; p<0.01). Results of the study can be concluded that steroid hormones have different effects on the quality indicators of fresh and cryopreserved sperm of stallions and their concentration in the blood should be considered when selecting stallions for cryopreservation of sperm.

31 December 2022 in Nauka Molodykh (Eruditio Juvenium)
Verified
Journal Article
Closed access
RURyazan State Medical University
Ryazan State Medical University
NSN.A. Savel’yEva
N.A. Savel’yEva
GMG.S. Mezhevikina
G.S. Mezhevikina
MDM.N. Dmitriyeva
M.N. Dmitriyeva
BACKGROUND: Preservation of pulp viability allows to preserve the integrity of tooth structures, the correct relationship with other elements of the dental system, therefore, the improvement of materials aimed at preventing endodontic treatment with preservation of the entire pulp is of great clinical importance. AIM: Comparison of clinical effectiveness of various materials in the vital therapy of permanent tooth pulp. MATERIALS AND METHODS: The study involved 30 patients (20 male and 10 female patients aged 11 to 25 years) divided into 3 groups. Vital pulp therapy of permanent molars and premolars with formed and unformed roots diagnosed as reversible pulpitis was carried out by direct and indirect coating with calcium hydroxide in group 1 (9 patients/18 teeth) (Calasept, with Dycal-isolated surface), with ProRootMTA in group 2 (10 patients/15 teeth) and with Biodentine in group 3 (11 patients/15 teeth). IRM (methyl methacrylate-reinforced zink-oxide-eugenol cement) was used as temporary filling. The research data were processed using nonparametric statistics. RESULTS: After 4 years of follow-up: After the first stage of observation, not in a single of 14 remaining teeth in group 1 (4 teeth were subjected to endodontic treatment), clinical and radiological signs of pulp pathology were found; in 3 teeth (21.4%), pronounced narrowing of the pulp chamber and obliteration of the pulp of canal orifice were noted, which did not require endodontic intervention. In group 2, of 13 teeth (2 teeth previously received endodontic treatment), 1 tooth (7.6%) was diagnosed with irreversible symptomatic pulpitis and 2 teeth (16.6%) — with pronounced narrowing of the pulp chamber, obliteration of the root pulp, 3 teeth (25%) — with denticles in the pulp chamber. In group 3, 2 teeth (13.3% of cases) were subjected to endodontic treatment for irreversible symptomatic pulpitis in 1.5 year after the beginning of the observation, and in 1 tooth (6.6%), the formation of multiple denticles in the pulp chamber was noted. CONCLUSION: Thus, the clinical and radiological effectiveness of use of calcium hydroxide in vital pulp therapy of permanent teeth after 12 months was 77.7% (14 of 18 teeth), of ProRootMTA — 86.6% (13 of 15 teeth) and of Biodentine — 100%, which absolutely correlates with the data of modern literature sources. In direct pulp coating (pulpcap) in permanent teeth, 100% excellent treatment results within 1 year were achieved only with Biodentine.

4 October 2024 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Closed access
PDF file
MKMikhail A. Kiselev
Mikhail A. Kiselev
NRNatalya B. Repina
Natalya B. Repina
ANAlexander A. Nikiforov
Alexander A. Nikiforov
LNLarisa V. Nikiforova
Larisa V. Nikiforova
MDMaria N. Dmitrieva
Maria N. Dmitrieva
AKAnton M. Kiselev
Anton M. Kiselev
INTRODUCTION: Endometriosis is a common disease that affects up to 15% of women in the reproductive period and leads to infertility in 25%–50% of cases. The diagnosis of endometriosis is delayed for years due to blurred and diverse clinical presentation, therefore, search for a noninvasive biomarker of endometriosis is an important problem of modern medicine. AIM: To study the significance of changes in the profile of biomarkers: regulator of Wnt/β-catenin signaling pathway (axis inhibition protein 1; AXIN-1), soluble cytokeratin 19 fragment (cytokeratin fragment antigen 21-1; CYFRA-21-1), cancer antigen 125 (carbohydrate antigen 125; CA-125) in blood plasma of patients with endometriosis-associated infertility (before surgery and in the postoperative period). MATERIALS AND METHODS: The study included two groups of female patients. The first group consisted of 20 patients of reproductive age with cystic ovarian endometriosis and infertility. All the patients underwent surgical intervention using a laparoscope and a video system, in all the patients the diagnosis of endometriosis was confirmed histologically. Three times in specified periods (before surgery, on the 10th day of the postoperative period, at 6 months), patients with cystic ovarian endometriosis and infertility were taken biomaterial (blood) with further determination of AXIN-1, CYFRA-21-1, CA-125 in blood plasma. The second group consisted of patients of reproductive age with no gynecological pathology. In the second group, biological material (blood) was taken once with further determination of AXIN-1, CYFRA-21-1, CA-125 in blood plasma. RESULTS: Based on the analysis of the measurement data and comparison of their levels, it was found that the content of the studied AXIN-1, СA-125 biomarkers in patients with cystic ovarian endometriosis and infertility was higher than in patients without gynecological pathology (p 0.05). As for CYFRA-21-1 biomarker, initially lower values were noted compared to the control group (p 0.05), however, in the postoperative period, the content of CYFRA-21-1 increased and reached values close to those of healthy patients. CONCLUSION: Determining the levels of AXIN-1, CYFRA-21-1 apoptosis biomarkers and CA-125 proliferation biomarker in blood of patients with endometriosis-associated infertility gives an insight into the pathophysiological processes in the endometrioid ovarian cysts and may be helpful in development of new noninvasive diagnostic methods and target treatment methods.